1st PAFSC Committee Recommends Approval for Products Including Eisai’s Lunesta

November 8, 2011
The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on New Drugs discussed and recommended approval for Eisai’s insomnia treatment Lunesta Tablets 1 mg, 2 mg, and 3 mg (eszopiclone) at a meeting on November 7. Lunesta is a...read more